Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Gross Profit (2017 - 2021)

Historic Gross Profit for Neurocrine Biosciences (NBIX) over the last 5 years, with Q3 2021 value amounting to $291.8 million.

  • Neurocrine Biosciences' Gross Profit rose 1407.35% to $291.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.1 billion, marking a year-over-year increase of 336.39%. This contributed to the annual value of $780.7 million for FY2019, which is 7491.66% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Gross Profit stood at $291.8 million for Q3 2021, which was up 1407.35% from $285.8 million recorded in Q2 2021.
  • In the past 5 years, Neurocrine Biosciences' Gross Profit ranged from a high of $300.0 million in Q2 2020 and a low of $6.3 million during Q2 2017
  • Its 5-year average for Gross Profit is $175.9 million, with a median of $181.9 million in 2019.
  • Per our database at Business Quant, Neurocrine Biosciences' Gross Profit soared by 143093.72% in 2018 and then plummeted by 473.33% in 2021.
  • Neurocrine Biosciences' Gross Profit (Quarter) stood at $93.8 million in 2017, then soared by 38.61% to $130.0 million in 2018, then soared by 85.88% to $241.6 million in 2019, then grew by 5.89% to $255.8 million in 2020, then increased by 14.07% to $291.8 million in 2021.
  • Its Gross Profit stands at $291.8 million for Q3 2021, versus $285.8 million for Q2 2021 and $233.7 million for Q1 2021.